These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 29103052)

  • 1. Increasing Efficiency of Recruitment in Early Parkinson's Disease Trials: A Case Study Examination of the STEADY-PD III Trial.
    Berk S; Greco BL; Biglan K; Kopil CM; Holloway RG; Meunier C; Simuni T
    J Parkinsons Dis; 2017; 7(4):685-693. PubMed ID: 29103052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of an online portal to facilitate clinical trial recruitment: a preliminary analysis of Fox Trial Finder.
    Rocker C; Cappelletti L; Marshall C; Meunier CC; Brooks DW; Sherer T; Chowdhury S
    J Parkinsons Dis; 2015; 5(1):55-66. PubMed ID: 25624422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re-Analysis of the STEADY-PD II Trial-Evidence for Slowing the Progression of Parkinson's Disease.
    Surmeier DJ; Nguyen JT; Lancki N; Venuto CS; Oakes D; Simuni T; Wyse RK
    Mov Disord; 2022 Feb; 37(2):334-342. PubMed ID: 34766657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enrollment of Participants From Marginalized Racial and Ethnic Groups: A Comparative Assessment of the STEADY-PD III and SURE-PD3 Trials.
    Di Luca DG; Macklin EA; Hodgeman K; Lopez G; Pothier L; Callahan KF; Lowell J; Chan J; Videnovic A; Lungu C; Lang AE; Litvan I; Schwarzschild MA; Simuni T
    Neurol Clin Pract; 2023 Feb; 13(1):e200113. PubMed ID: 36865634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment and Retention in Clinical Trials of Deep Brain Stimulation in Early-Stage Parkinson's Disease: Past Experiences and Future Considerations.
    Grace Cannard K; Hacker ML; Molinari A; Heusinkveld LE; Currie AD; Charles D
    J Parkinsons Dis; 2018; 8(3):421-428. PubMed ID: 30010145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson's disease (STEADY-PD).
    Parkinson Study Group
    Mov Disord; 2013 Nov; 28(13):1823-31. PubMed ID: 24123224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Communicating with participants during the conduct of multi-center clinical trials.
    Augustine EF; Dorsey ER; Hauser RA; Elm JJ; Tilley BC; Kieburtz KK
    Clin Trials; 2016 Dec; 13(6):592-596. PubMed ID: 27573636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design innovations and baseline findings in a long-term Parkinson's trial: the National Institute of Neurological Disorders and Stroke Exploratory Trials in Parkinson's Disease Long-Term Study-1.
    Elm JJ;
    Mov Disord; 2012 Oct; 27(12):1513-21. PubMed ID: 23079770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recruitment for Remote Decentralized Studies in Parkinson's Disease.
    Myers TL; Augustine EF; Baloga E; Daeschler M; Cannon P; Rowbotham H; Chanoff E; ; Jensen-Roberts S; Soto J; Holloway RG; Marras C; Tanner CM; Dorsey ER; Schneider RB
    J Parkinsons Dis; 2022; 12(1):371-380. PubMed ID: 34744053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a virtual longitudinal observational study in Parkinson's disease (AT-HOME PD).
    Schneider RB; Omberg L; Macklin EA; Daeschler M; Bataille L; Anthwal S; Myers TL; Baloga E; Duquette S; Snyder P; Amodeo K; Tarolli CG; Adams JL; Callahan KF; Gottesman J; Kopil CM; Lungu C; Ascherio A; Beck JC; Biglan K; Espay AJ; Tanner C; Oakes D; Shoulson I; Novak D; Kayson E; Ray Dorsey E; Mangravite L; Schwarzschild MA; Simuni T;
    Ann Clin Transl Neurol; 2021 Feb; 8(2):308-320. PubMed ID: 33350601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing the Fostering Inclusivity in Research Engagement for Underrepresented Populations in Parkinson's Disease study.
    Sanchez AV; Ison JM; Hemley H; Willis A; Siddiqi B; Macklin EA; Ulysse C; Reynolds M; Schwarzschild MA; Jackson JD
    Contemp Clin Trials; 2022 Apr; 115():106713. PubMed ID: 35202842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.
    Dobkin RD; Amondikar N; Kopil C; Caspell-Garcia C; Brown E; Chahine LM; Marras C; Dahodwala N; Mantri S; Standaert DG; Dean M; Shoulson I; Marek K; Katz A; Korell M; Riley L; Tanner CM;
    J Parkinsons Dis; 2020; 10(2):665-675. PubMed ID: 32250321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of Virtual Research Visits in Fox Trial Finder.
    Dorsey ER; Wagner JD; Bull MT; Rizzieri A; Grischkan J; Achey MA; Sherer T; Chowdhury S; Meunier C; Cappelletti L; Rocker C; Richard IH; Schwarz H; Kang G; Ahmad SH; Biemiller RA; Biglan KM
    J Parkinsons Dis; 2015; 5(3):505-15. PubMed ID: 26406130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1.
    Wills AM; Pérez A; Wang J; Su X; Morgan J; Rajan SS; Leehey MA; Pontone GM; Chou KL; Umeh C; Mari Z; Boyd J;
    JAMA Neurol; 2016 Mar; 73(3):321-8. PubMed ID: 26751506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson's Disease.
    Heusinkveld L; Hacker M; Turchan M; Bollig M; Tamargo C; Fisher W; McLaughlin L; Martig A; Charles D
    J Parkinsons Dis; 2017; 7(1):89-94. PubMed ID: 27911344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility, Reliability, and Value of Remote Video-Based Trial Visits in Parkinson's Disease.
    Tarolli CG; Andrzejewski K; Zimmerman GA; Bull M; Goldenthal S; Auinger P; O'Brien M; Dorsey ER; Biglan K; Simuni T
    J Parkinsons Dis; 2020; 10(4):1779-1786. PubMed ID: 32894251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recruitment strategies and patient selection in clinical trials for Parkinson's disease: Going viral and keeping science and ethics at the highest standards.
    Picillo M; Kou N; Barone P; Fasano A
    Parkinsonism Relat Disord; 2015 Sep; 21(9):1041-8. PubMed ID: 26228079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized recruitment intervention trial in Parkinson's disease to increase participant diversity: early stopping for lack of efficacy.
    Tilley BC; Mainous AG; Elm JJ; Pickelsimer E; Soderstrom LH; Ford ME; Diaz VA; Siminoff LA; Burau K; Smith DW
    Clin Trials; 2012 Apr; 9(2):188-97. PubMed ID: 22496398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using increased trust in medical researchers to increase minority recruitment: The RECRUIT cluster randomized clinical trial.
    Tilley BC; Mainous AG; Amorrortu RP; McKee MD; Smith DW; Li R; DeSantis SM; Vernon SW; Koch G; Ford ME; Diaz V; Alvidrez J;
    Contemp Clin Trials; 2021 Oct; 109():106519. PubMed ID: 34333138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minority recruitment to the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
    Cook ED; Moody-Thomas S; Anderson KB; Campbell R; Hamilton SJ; Harrington JM; Lippman SM; Minasian LM; Paskett ED; Craine S; Arnold KB; Probstfield JL
    Clin Trials; 2005; 2(5):436-42. PubMed ID: 16315648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.